Filing Flows › Comparisons › ISCO vs LPCN
International Stem Cell vs Lipocine: ISCO and LPCN compared
International Stem Cell is the larger company: $2.7M of revenue in its latest quarter (Q2 2026) against $2.3M for Lipocine (Q3 2026). Lipocine is growing faster (20× against +9% a year earlier). International Stem Cell is more profitable, with an operating margin of -1.3% against -37.9%.
Where the money goes: ISCO and LPCN
International Stem Cell (ISCO) · Q2 2026
International Stem Cell, Q2 2026: revenue $2.7M (+9% year over year), operating margin -1.3%, net loss $71K, operating cash flow $167K. The chart follows the revenue to costs, profit and cash.
Lipocine (LPCN) · Q3 2026
Lipocine, Q3 2026: revenue $2.3M (20× year over year), operating margin -37.9%, net loss $666K, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
| International Stem Cell (ISCO) | Lipocine (LPCN) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $2.7M | $2.3M |
| Revenue growth, Y/Y | +9% | 20× |
| Operating margin | -1.3% | -37.9% |
| Net earnings | −$71K | −$666K |
| Net margin | -2.7% | -29.1% |
| Operating cash flow | $167K | −$1.8M |
| Free cash flow | $160K | — |
Where the revenue comes from
International Stem Cell
- Biomedical Market: $2.5M (94%)
- Anti Aging Skincare Market: $151K (6%)
Questions
Which is bigger, International Stem Cell or Lipocine?
International Stem Cell is the larger company: $2.7M of revenue in its latest quarter (Q2 2026) against $2.3M for Lipocine (Q3 2026).
Is International Stem Cell or Lipocine growing faster?
Lipocine is growing faster (20× against +9% a year earlier).
Which is more profitable, International Stem Cell or Lipocine?
International Stem Cell is more profitable, with an operating margin of -1.3% against -37.9%.
More: International Stem Cell earnings · how International Stem Cell makes money · Lipocine earnings · how Lipocine makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.